Aarti Drugs Limited Financial Overview
Aarti Drugs Limited's market cap is currently ₹35.24B. The company's EPS TTM is ₹4.9; its P/E ratio is 18.93; and it has a dividend yield of 0.24%. Aarti Drugs Limited is scheduled to report earnings on November 7, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
